11 October 2011
State-of the art brain imaging explored in Journal of Alzheimer’s Disease Supplement
3 October 2011
A team of scientists, led by Johns Hopkins researchers, say they may have found a way to predict how quickly patients with Alzheimer’s disease (AD) will lose cognitive function by looking at ratios of two fatty compounds in their blood.
6 September 2011
London, UK – UK scientists have uncovered how a known risk gene for Alzheimer’s might play a role in the development of the disease.
15 July 2011
Natural Chemical Found In Grapes May Protect Against Alzheimer’s Disease by Decreasing Neurotoxins in the Brain
New York, NY, USA – Researchers at Mount Sinai School of Medicine have found that grape seed polyphenols—a natural antioxidant—may help prevent the development or delay the progression of Alzheimer’s disease.
21 June 2011
Tampa, FL – A yet unidentified component of coffee interacts with the beverage’s caffeine, which could be a surprising reason why daily coffee intake protects against Alzheimer’s disease. A new Alzheimer’s mouse study by researchers at the University of South Florida found that this interaction
20 June 2011
Amsterdam, The Netherlands -- After more than 100 years following its pathologic description, the cause of Alzheimer’s disease (AD) remains unknown.
13 June 2011
Scientists in London have found that a protein increased during exercise could help protect against Alzheimer’s disease. It’s hoped their findings could be used to design drugs to fight the disease.
4 May 2011
Montreal, Quebec, Canada - A new blood test that will diagnose Alzheimer’s disease may soon hit the market, thanks to an innovative study from the Research Institute of the McGill University Health Centre (MUHC).
27 April 2011
Tampa, FL, USA -Cotinine, a compound derived from tobacco, reduced plaques associated with dementia and prevented memory loss in a mouse model of Alzheimer’s disease, a study led by researchers at Bay Pines VA Healthcare System and the University of South Florida found.
13 March 2011
Los Angeles, CA, USA - UCLA researchers have identified a new biomarker that could help them track how effectively the immune system is able to clear the brain of amyloid beta, which forms the plaques considered one of the hallmarks of Alzheimer's disease.